CNAT - Conatus Pharmaceuticals Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
No. of Analysts3333
Avg. Estimate-0.12-0.07-0.36-0.52
Low Estimate-0.16-0.16-0.6-0.82
High Estimate-0.070-0.21-0.27
Year Ago EPS-0.17-0.15-0.59-0.36
Revenue EstimateCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
No. of Analysts3332
Avg. Estimate8.26M9.49M32.85M17.5M
Low Estimate7.5M7.47M24.55MN/A
High Estimate8.79M12.5M40M35M
Year Ago Sales9.74M8.77M33.59M32.85M
Sales Growth (year/est)-15.20%8.20%-2.20%-46.70%
Earnings History3/30/20186/29/20189/29/201812/30/2018
EPS Est.-0.17-0.2-0.15-0.14
EPS Actual-0.17-0.15-0.15-0.13
Difference00.0500.01
Surprise %0.00%25.00%0.00%7.10%
EPS TrendCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.12-0.07-0.36-0.52
7 Days Ago-0.12-0.07-0.36-0.52
30 Days Ago-0.14-0.09-0.17-0.24
60 Days Ago-0.13-0.03-0.16-0.41
90 Days Ago-0.13-0.03-0.16-0.41
EPS RevisionsCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days2121
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesCNATIndustrySectorS&P 500
Current Qtr.29.40%N/AN/A-0.02
Next Qtr.53.30%N/AN/A0.04
Current Year39.00%N/AN/A0.05
Next Year-44.40%N/AN/A0.11
Next 5 Years (per annum)38.00%N/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A